According to the Market Statsville Group (MSG), the global bioimpedance sensor market size is expected to grow from USD 10,173.2 million in 2022 to USD 12,521.6 million by 2033, growing at a CAGR of 7.2% from 2023 to 2033. The rising frequency of metabolic illnesses, expanding government programmers to encourage healthy lifestyles, and developing technical developments are all driving market expansion. Diabetes, Gaucher's disease, glucose-galactose malabsorption, hereditary hemochromatosis, maple syrup urine disease (MSUD), phenylketonuria (PKU), and other metabolic diseases are projected to be important factors driving demand for bioimpedance sensors, hence enhancing market growth. On the other hand, less availability of miniaturized instrumentation, novel models, and algorithms has hindered the market growth over the forecasting period.
In additional, advances in electronics and instrumentation technology and novel textile materials and textile-electronic integration techniques have encouraged the development and implementation of sensorized garments for wearable biomedical monitoring systems. This has created a lot of opportunities in the market over the forecasting period.
Population aging and the consequent increase in chronic patients are driving research and development of multiple biomedical sensor technologies. These enable more accurate monitoring and diagnosis of people's health, paving the way for more personalised, preventive, and proactive treatment. Bioimpedance technology provides important insights into tissue/cell physiology and disease. Bioimpedance sensors are forming the foundation for innovative and noninvasive medical diagnostic technologies in this approach. Bioimpedance measurements are used to characterise biological media and organic tissues and have been used to detect edema, diagnose skin diseases, detect cancerous tissues, monitor ischemia during the transplant process, and even estimate blood pressure and blood glucose levels in a noninvasive and nonobstructive manner. Bioimpedance techniques are also the foundation of various laboratory instruments for cell culture monitoring and cell mechanical properties research (population, motility, viability, and others).
Further, several wearables and textile-enable monitoring systems for non-invasive measurements have been designed and implemented as a result of extensive and numerous research efforts, such as a sensorized chest strap for cardiopulmonary activity status during emergencies and a sensorized vest incorporating fully woven textile sensors. Thus, bioimpedance has the potential to play an important role in this scope, especially because of its relatively reliable, electrode-based sensing principle and its broad range of applications.
The COVID-19 pandemic is predicted to benefit the bioimpedance analyzers industry. According to the WHO, more than 95% of deaths in Europe occurred in patients over the age of 60, and more than 50% of all global fatalities were those aged 80 or older. According to WHO research, eight out of ten fatalities occurred in people who had at least one comorbidity, such as CVD, hypertension, or diabetes.
COVID-19 induces muscular breakdown and a reduction in appetite. This results in malnutrition and substantial muscle mass loss. This is especially essential for obese people, who already have relatively poor muscle mass. The European Society for Clinical Nutrition and Metabolism (ESPEN) provides practical advice for COVID-19 patients' dietary treatment, emphasizing the importance of muscle mass. Consequently, measuring body composition and muscle mass both during and after hospitalization is critical for protecting patients as well as managing and monitoring their progress.
The surge in preference for bioimpedance sensors for chronic disease management coupled with the robust growth of the geriatric population with ailments that require quick treatments, for instance, diabetes, heart failure, and chronic obstructive pulmonary disease (COPD), and more are the key forces that stimulate the demand for bioimpedance sensor market. A wearable bioimpedance monitoring system is an electronic device with a bioimpedance sensor that captures the wearer's bioimpedance and is worn close to or on the skin's surface, allowing the wearer to move freely during daily living situations (i.e., that is not attached to any main power supply or desktop device). Bioimpedance is a flexible sensing technology that can be utilized for various clinical and lifestyle applications, including body fluid monitoring, gesture monitoring, and hemodynamic parameter monitoring. This enables the shift in trend to bioimpedance sensors from the traditional healthcare system to amplify the demand for the bioimpedance sensor market.
Moreover, remote monitoring is being applied on a relatively limited basis in emerging nations, but they are gaining significant traction in the developed world, especially for chronic diseases. Since this device is recognized in the developed world and funding models develop in emerging countries, bioimpedance sensor is expected to become widespread and significantly improve health outcomes for an extensive range of infectious and chronic diseases. Thus, the rising prevalence of chronic conditions such as diabetes and growing awareness among patients towards health is the prime factors propelling the market growth.
Bioimpedance devices are non-invasive, low-cost, portable, and user-friendly, all of which have contributed to their rapid growth. However, as more efficient and miniaturized instruments, novel models and algorithms, new parameters, and substance characterizations are required, bioimpedance research is a particularly active sector. Sensor sensitivity and power consumption must be optimized, notably in Lab-on-Chip devices and implanted systems such as cardiac and other monitors and pacemakers. Because this technology's repeatability and reproducibility are frequently limited, novel sensing techniques are required. Furthermore, high frequency measurements necessitate in-depth circuit design methodologies to overcome challenges.
Further, the challenge of portability in bioimpedance systems, since the typical applications of bioimpedance measurement on the human body (BIA, ICG, TIP, EIT, and EDA) use electrodes on the skin. Because the most common applications of bioimpedance measurement on the human body (BIA, ICG, TIP, EIT, and EDA) employ electrodes on the skin, portability is a challenge in bioimpedance systems.
In the recent decade, advances in electronics and instrumentation technology and novel textile materials and textile-electronic integration techniques have encouraged the development and implementation of sensorized garments for wearable biomedical monitoring systems. Several wearables and textile-enable monitoring systems for non-invasive measurements have been designed and implemented as a result of extensive and numerous research efforts, such as a sensorized chest strap for cardiopulmonary activity status during emergencies and a sensorized vest incorporating fully woven textile sensors.
Bioimpedance has the potential to play an important role in this scope, especially because of its relatively reliable, electrode-based sensing principle and its broad range of applications. As it is a non-invasive, low-cost, and adaptable method, bioimpedance technology has significant advantages over traditional methods. Furthermore, incorporating bio signal sensing garments into home e-Healthcare Systems for multi-parametric patient monitoring can provide considerable benefits. One of the advantages of these garments is that they may be worn, which aids in precise electrode location, functionality, and comfort.
The study categorizes the bioimpedance sensor market based on type, and application area at the regional and global levels.
Based on the application, the market is divided into personal fitness tracking, medical use, and others. The medical use segment is expected to dominate the market share in 2022 in the global bioimpedance sensor market. The medical use segment currently dominates the market share in the bioimpedance sensor market. Owing to the rapid advancements in the field of tissue engineering, the deployment of real-time, non-invasive, and non-destructive monitoring technologies for assessing the viability and properties of cell cultures. The bioimpedance techniques help access the electrical properties of living tissues and provide a non-invasive, label-free, and real-time solution for monitoring tissue-created structures. The principles of bioimpedance, as well as the electrical properties of biological tissues, different types of cell culture constructions, and possible electrode configuration set ups for performing bioimpedance measurements on the cell culture engineering.
Based on the regions, the global bioimpedance sensor market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. North America is projected to account for the highest market share in 2022. The rising prevalence of metabolic illnesses is likely to enhance demand for bioimpedance analyzers due to the effective management of the disorders, fueling market expansion in this area. Furthermore, increased government measures to encourage a healthy lifestyle and achieve a healthy weight with better well-being are likely to drive market expansion during the forecast period. According to the America Health Ranking 2022 study, there were more than 55.6 million individuals aged 65 and over in the United States in 2021, with that number predicted to rise to 73.1 million by 2030. Furthermore, according to statistics released in the National Library of Medicine in December 2021, hereditary hemochromatosis is the most common autosomal recessive disorder among Americans, with an annual incidence of 1 in 300 to 500 persons.
The bioimpedance sensor market is a significant competitor, and extremely cutthroat in the sector are using strategies including product launches, partnerships, acquisitions, agreements, and growth to enhance their market positions. Most sector businesses focus on increasing their operations worldwide and cultivating long-lasting partnerships.
Key Issues Addressed
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Student Loan Servicing Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024Lab Automation Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast by 2027
Mar 2024Retail Automation Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030
Mar 2024Mobility As A Service (Maas) Market 2023: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024Web 3.0 Blockchain Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024